One Day MD

SYDNEY, Oct 14, 2021 - (ACN Newswire) - Topelia Australia, a biotech company established to commercialise a novel ATT treatment for Australians in quarantine, has launched an investment program designed to keep the invention Australian owned - while rolling out treatment to the world. - Topelia announces US$25 mil Series A capital raise to fund manufacture and clinical trials of the COVID-19 Antiviral Triple Therapy (ATT). - Topelia has secured exclusive global patent rights to COVID-19 Antiviral Triple Therapy from Prof Thomas Borody. - Borody's track record includes effective treatment for Peptic Ulcers & Crohn's Disease, recolonisation of bowel microbiome, and 3 FDA approved drugs on the market. - Based on current research, the ATT provides an inexpensive and medically efficacious treatment for the prevention and early treatment of COVID-19. The company is raising USD$25 million from investors in Australia, Asia and USA. The company said: "Topelia proposes to offer

A   Sydney   gastroenterologist who has been enthusiastically promoting an unapproved Covid-19 treatment, including to Australian politicians and general practitioners, has filed a patent in the US for the same treatment, allowing him to commercialise and profit from it, if approved. Prof Thomas Borody has been quoted  in medical newsletters  and  publications , and in news outlets including the  Financial Review , the  Daily Telegraph  and  the Australian , promoting what he describes as a “triple therapy protocol” to treat and cure Covid-19. The protocol involves a combination of the anti-parasitic drug ivermectin, zinc and the antibiotic doxycycline. In December 2020 Borody filed a patent in the US for therapeutic combinations of drugs, including a combination of ivermectin, an antibiotic and zinc. Patenting a treatment means the owner of the patent is allowed to exclusively manufacture, market and profit from the drug until the patent expires, usually after 20 years. Borody did not

Have you heard about peptides? They’ve been praised for their many health benefits, but there’s some confusion about them. What are they, what do they do, and who should take them? In this article, we’ll explain the science behind peptide therapy, as well as its many benefits and uses. How A Breakthrough Treatment is Providing Relief for Mind and Body What are Peptides? Peptides are the building blocks of proteins. They are comprised of amino acids bound together in chains. When these chains connect together, they form a protein. It should be noted that peptides are not proteins. Amino acids make up both, but protein contains higher amounts of amino acids than peptides. This actually makes peptides easier to absorb than proteins since they are smaller. Peptides facilitate cell-to-cell communication, essentially telling the body which cells to turn on and off. This means you can re-activate cells that may have gone dormant or need an extra boost. Some peptides occur naturally, and some

While all viruses spread and replicate, doctors are concerned about how rapidly the Delta variant is spreading. The Delta variant (also referred to as B.1.617.2) of COVID-19 is a newer strain of the COVID-19 virus that appears to spread more easily and quickly than other variants, which may lead to more cases of COVID-19. It was initially identified in India in December 2020 and was first detected in the United States in March 2021. Update: COVID-19 Omicron Variant: Symptoms and Treatment ?   Credit: Getty Images COVID-19 Delta Variant Symptoms The COVID-19 Delta variant may have symptoms that differ slightly from the original coronavirus strain and include: Headache Sore throat Runny nose Fever  Cough and loss of smell are less common with the Delta variant compared to the original coronavirus strain  ( Source ). Other symptoms of COVID-19 may include: Shortness of breath Chills Muscle pain/body aches Changes in or loss of sense of taste Fatigue Diarrhea Nausea Vomiting Loss of appet

Regenexx -  Do you remember that famous 1970s TV quote, “I’m not a doctor, but I play one on TV”? Well, that’s what some research scientists are doing. Let’s dig into that today. Ph.D. vs. M.D. A Ph.D. is someone who begins with a Bachelors in Science degree and then takes additional graduate-level course work in their field. Ultimately, on the lab research side, they work in a lab and then perform original research and rigorously defend a thesis, which can take years. An M.D. (or D.O.) is someone who went to medical school, and then a hospital internship, years of residency training in a hospital, and often subspeciality training. There are boards to sit for, licensing tests to take, and finally, after you’ve given away your 20s, you’re finally a practicing physician. Hence, what do Ph.D.’s know about medicine? Not much outside of their very specific fields. Meaning if a lab Ph.D. tried to treat a patient or provide advice to a patient, that could be practicing medicine without traini